Mural Oncology Plc Stock Probability of Future Stock Price Finishing Over 3.13
| MURA Stock | 3.44 0.20 5.49% |
Mural |
Mural Oncology Target Price Odds to finish over 3.13
The tendency of Mural Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay above 3.13 in 90 days |
| 3.44 | 90 days | 3.13 | about 92.57 |
Based on a normal probability distribution, the odds of Mural Oncology to stay above 3.13 in 90 days from now is about 92.57 (This Mural Oncology plc probability density function shows the probability of Mural Stock to fall within a particular range of prices over 90 days) . Probability of Mural Oncology plc price to stay between 3.13 and its current price of 3.44 at the end of the 90-day period is about 30.91 .
Given the investment horizon of 90 days Mural Oncology has a beta of 0.91. This indicates Mural Oncology plc market returns are sensitive to returns on the market. As the market goes up or down, Mural Oncology is expected to follow. Additionally Mural Oncology plc has an alpha of 0.0375, implying that it can generate a 0.0375 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Mural Oncology Price Density |
| Price |
Predictive Modules for Mural Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mural Oncology plc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mural Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Mural Oncology is not an exception. The market had few large corrections towards the Mural Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Mural Oncology plc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Mural Oncology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.91 | |
σ | Overall volatility | 0.27 | |
Ir | Information ratio | 0.01 |
Mural Oncology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Mural Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Mural Oncology plc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Mural Oncology plc had very high historical volatility over the last 90 days | |
| Mural Oncology plc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (207.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mural Oncology generates negative cash flow from operations | |
| Mural Oncology plc has a frail financial position based on the latest SEC disclosures | |
| About 69.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
Mural Oncology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Mural Stock often depends not only on the future outlook of the current and potential Mural Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mural Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 16.7 M | |
| Cash And Short Term Investments | 270.9 M |
Mural Oncology Technical Analysis
Mural Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Mural Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Mural Oncology plc. In general, you should focus on analyzing Mural Stock price patterns and their correlations with different microeconomic environments and drivers.
Mural Oncology Predictive Forecast Models
Mural Oncology's time-series forecasting models is one of many Mural Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Mural Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Mural Oncology plc
Checking the ongoing alerts about Mural Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Mural Oncology plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Mural Oncology plc had very high historical volatility over the last 90 days | |
| Mural Oncology plc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (207.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mural Oncology generates negative cash flow from operations | |
| Mural Oncology plc has a frail financial position based on the latest SEC disclosures | |
| About 69.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
Check out Mural Oncology Backtesting, Mural Oncology Valuation, Mural Oncology Correlation, Mural Oncology Hype Analysis, Mural Oncology Volatility, Mural Oncology History as well as Mural Oncology Performance. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.03) | Return On Assets (0.81) | Return On Equity (1.78) |
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.